Key Developments: Pain Therapeutics Inc (PTIE.O)

PTIE.O on Nasdaq

1.89USD
31 Mar 2015
Change (% chg)

-- (--)
Prev Close
$1.89
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
108,557
52-wk High
$6.22
52-wk Low
$1.61

Search Stocks

Latest Key Developments (Source: Significant Developments)

Pfizer to discontinue agreement on REMOXY extended-release capsules CII with Pain Therapeutics, Inc
Monday, 27 Oct 2014 08:00am EDT 

Pfizer Inc:To discontinue its agreement to develop and commercialize REMOXY (oxycodone) Extended-Release Capsules CII, an investigational extended-release oral formulation of oxycodone.To return all rights, including responsibility for regulatory activities, to Pain Therapeutics, Inc.  Full Article

Photo

Pfizer ends deal with Pain Therapeutics to develop Durect's pain drug

- Pfizer Inc ended an agreement with Pain Therapeutics Inc to develop and market Durect Corp's pain drug, Remoxy, sending the stocks of the two smaller drugmakers plummeting.

Search Stocks